Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so.
The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.
Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.
Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so.
